ArticleFrontiers in immunology2023

Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center.

Danqing Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.